Overview:

Inspire is the only FDA-approved treatment specifically designed to address the root cause of obstructive sleep apnea (OSA) with the convenience of a simple button press. This innovative therapy involves a small device implanted in the body through two small incisions during a same-day outpatient procedure. Inspire works by delivering gentle pulses to keep the airway open during sleep, allowing for natural breathing and restful sleep.

How Inspire Works:

•  Implantation: The Inspire device is implanted through a minimally invasive procedure, typically completed in a single day.
• Activation: After the procedure, patients meet with their physician, such as Dr. Kagzi, to fine-tune the device settings.
• Nightly Use: Each night, the patient uses a remote control to activate Inspire before going to sleep. While the patient sleeps, Inspire monitors breathing patterns and gently stimulates the hypoglossal nerve to move the tongue and maintain an open airway.

Inspire Therapy at MSI:

Evaluation Protocol:

Patient Qualification Criteria:

• Diagnosed with moderate to severe obstructive sleep apnea (Apnea-Hypopnea Index, AHI between 15 and 65).
• Body Mass Index (BMI) less than 40 for private insurance or less than 35 for Medicare.
• Previous unsuccessful attempts with CPAP, APAP, or BiPAP therapy.

Referral Process:

• Patients who meet the qualification criteria are referred to a local ENT specialist certified by Inspire to perform the implantation procedure.

Post-Implant Process:

• After the device is implanted, patients return to our CERN office for activation and fine-tuning of the Inspire device.
  Once optimized, an overnight Inspire titration (ESG) study is scheduled to document the effectiveness of the treatment.

Inspire therapy offers a promising alternative for patients who have struggled with traditional OSA treatments, providing a tailored approach to improving sleep quality and overall health.